Cambridge Glycoscience raises $15 million Series A for fiber-based sweetener and rebrands as Supplant

March 05, 2021 | News Commentary

This funding round was led by existing investors including Felicis Ventures and Manta Ray, bringing Supplant's funding to $24 million. Previously known as Cambridge Glycoscience, the company develops oligosaccharide-based sweetener...